Vaccines against leishmaniasis

REFERENCES

• Afonso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G. & Scott, P. (1993). The adjuvant effect of interleukin-12 in a vaccine against L. major. Science, 263, 235–237.
   Web of Science ®Google Scholar
• Alimohammadian, M. H., Kivanjah, M., Pak, F., Ghaznavi, A. & Kharazmi, A. (1993). Evaluation of efficacy of Iran leishmanin and comparison with leishmanin from Wellcome (U.K.) and Roma, Italy in cured cutaneous leishmaniasis patients. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 550–551.
   PubMed Web of Science ®Google Scholar
• Antunes, C. M. F., Mayrink, W., Magalhaes, P. A., Costa, A., Melo, M. N., Dias, M., Michalick, M. S. M., Williams, P., Lima, A. O., Vieira, J. B. F. & Schetini, A. P. M. (1986). Controlled field trials of a vaccine against New World cutaneous leishmaniasis. International Journal of Epidemiology, 15, 572–580.
   PubMed Web of Science ®Google Scholar
• Bahar, K., Shtoani, B., Dowlati, Y., Deihimi, I., Fesharki, R., Ale-Agha, S., Sepehrzad, C., Shafyii, A. & Ehsassi, S. (1993). Overview of human vaccine studies using killed L. major. In 13th International Congress for Tropical Medicine and Malaria Faculty of Tropical Medicine, Mahidol University, Bangkok, Abstracts, Vol. 1, p. 183.
   Google Scholar
• Castes, M., Blackwell, J., Trujillo, D., Formica, S., Cabrera, M., Zorrilla, G., Rodas, A., Castellanos, P. L. & Convit, J. (1994). Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I. Skin test reactivity T cell proliferation and interferon-gamma production. Vaccine, 12, 1041–1051.
   PubMed Web of Science ®Google Scholar
• Castes, M., Trujillo, D., Calcagno, M., Cabrera, M. & Convit, J. (1993). Response Th1-Th2 in human American cutaneous leishmaniasis: its possible relevance for design of a vaccine. Memorías do Instituto Oswaldo Cruz, 88, 42–43.
   Google Scholar
• Connell, N. D., Medina-Acosta, E., Mcmaster, R. W., Bloom, B. R. & Russell, D. G. (1993). Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface protease gp63. Proceedings of the National Academy of Sciences of the United States of America, 90, 11473–11477.
   PubMed Web of Science ®Google Scholar
• Convit, J., Rondon, A., Ulrich, M., Bloom, B., Castellanos, P. L., Pinardi, M., Castes, M. & Garcia, M. (1987). Immunotherapy versus chemotherapy in localized cutaneous leishmaniasis. Lancet, i, 401–404.
   Google Scholar
• Cruz, A., Coburn, C. M. & Beverley, S. M. (1991). Double targeted gene replacement for creating null mutants. Proceedings of the National Academy of Sciences of the United States of America, 88, 7170–7174.
   PubMed Web of Science ®Google Scholar
• Hashemi-Fesharki, R., Ale-Agha, S., Ahourai, P., Djavadian, E., Taghavi, A., Golabi, A., Kamali, M., Esamail-Nia, K., Ghafari, H., Mofasali, F. & Kheirol-Omour, R. (1993). Vaccine preparation and quality control of killed Leishmania major. Archives de l'Institut Razi, 42/43, 39–50.
   Google Scholar
• Jardim, A., Alexander, A., Teh, H. S., Ou, D. & Olafson, R. W. (1990). Immunoreactive Leishmania major synthetic T cell epitope. Journal of Experimental Medicine, 172, 645–648.
   PubMed Web of Science ®Google Scholar
• Jardim, A., Tolson, D. L., Turco, S. J., Pearson, T. W. & Olafson, R. W. (1991). The Leishmania donovani lipophosphoglycan T lymphocyte reactive component in a tightly associated protein complex. Journal of Immunology, 147, 3538–3544.
   PubMed Web of Science ®Google Scholar
• McMahon-Pratt, D., Rodriguez, D., Rodriguez, J. R., Zhang, Y., Manson, K., Bergman, C., Rivas, L., Rodriguez, J. F., Lohman, K. L., Ruddle, N. H. & Esteban, M. (1993). Recombinant vaccinia viruses expressing GP42/M-2 protect against Leishmania infection. Infection and Immunity, 61, 3351–3359.
   PubMed Web of Science ®Google Scholar
• Mendonca, S. C. F., De Luca, P., Mayrink, W., Restom, T., Conceicao-Silva, F., Da Cruz, A. M., Bertho, A. L., Da Costa, C. A., Genaro, O., Toledo, V. P. C. P. & Coutinho, S. G. (1995). Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis. Infection and Immunity, in press.
   Google Scholar
• Moll, H., Mitchell, G. F., McConville, M. J. & Handman, E. (1989). Evidence for T cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Infection and Immunity, 57, 3349–3356.
   PubMed Web of Science ®Google Scholar
• Mougneau, E., Altare, F., Wakil, A. E., Zheng, S., Coppola, T., Wang, Z., Waldman, R., Locksley, R. & Glaichenhaus, N. (1994). Expression cloning of a Leishmania major protective T cell antigen. Science, 268, 563–566.
   Web of Science ®Google Scholar
• Muller, I., Pedrazzumi, T., Krope, P., Louis, J. & Milon, G. (1991). Establishment of resistance to L. major infection in susceptible BALB/C mice requires parasite-specific CD8+ T cells. International Immunology, 3, 587–592.
   PubMed Web of Science ®Google Scholar
• Rachamim, N. & Jaffe, C. L. (1993). Pure protein from L. donovani protects mice against both cutaneous and visceral leishmaniasis. Journal of Immunology, 150, 2322–2331.
   PubMed Web of Science ®Google Scholar
• Rivas, L., Kahl, L., Manson, K. & McMahon-Pratt, D. (1991). Biochemical characterization of the protective membrane glycoprotein GP46/M-2 of Leishmania amazonensis. Molecular and Biochemical Parasitology, 47, 235–243.
   PubMed Web of Science ®Google Scholar
• Russo, D. M., Burns Jr, J. M., Carvalho, E. M., Armitage, R. J., Grabstein, K. L., Button, L. L., McMaster, W. R. & Reed, S. G. (1991). Human T cell responses to rgp63, a surface antigen of Leishmania. Journal of Immunology, 147, 3575–3580.
   PubMed Web of Science ®Google Scholar
• Sheiky, Y. A. W., Benson, D. R., Elwasila, M., Badaro, R., Burns, J. M. & Reed, S. G. (1994). Shared antigens between Leishmania and Trypanosoma cruzi: characterization of the Leishmania chagasi acidic ribosomal protein PO. Infection and Immunity, 62, 1643–1651.
   PubMed Web of Science ®Google Scholar
• Souza, A. E., Bates, P. A., Coombs, G. H. & Mottram, J. C. (1994). Null mutants for the lmcpa cysteine proteinase gene in Leishmania mexicana. Molecular and Biochemical Parasitology, 63, 213–220.
   PubMed Web of Science ®Google Scholar
• Titus, R. G., Gueiros-Filho, F., De Freitas, L. A. & Beverley, S. M. (1995). Proceedings of the National Academy of Sciences of the United States of America. (In press).
   Google Scholar
• Yang, D. M., Fairweather, N., Button, L., McMaster, W. R., Kahl, L. P. & Liew, F. Y. (1990). Oral S. typhimurium (AroA−) vaccine expressing leishmanial surface protein (gp63) preferentially induced Th1 cells and protective immunity against leishmaniasis. Journal of Immunology, 145, 2281–2285.
   PubMed Web of Science ®Google Scholar